Jacqueline Norris‐Drouin
Papers
1
Total Citations
11
H-Index
1
About
Jacqueline Norris‐Drouin is a leading chemical biologist whose research centers on fragment-based drug discovery, chemical probe development, and the targeting of challenging proteins for cancer therapy. Her most notable contribution is the creation of FRASE-bot, an innovative in silico platform that integrates fragment screening with structure-based design to rapidly identify small-molecule inhibitors. In her landmark 2024 study, she applied this approach to discover CIB1-directed anti-tumor agents, demonstrating how computational methods can overcome the difficulties of drugging previously intractable targets. This work, already garnering 11 citations, exemplifies her skill in bridging computational chemistry and experimental validation. Norris‐Drouin’s research has profound implications for precision oncology, offering a scalable strategy to generate chemical probes for understudied proteins. Her achievements include pioneering the FRASE-bot methodology, which promises to accelerate the translation of biological insights into therapeutic leads. For students and researchers, her work illustrates how creative computational tools can unlock new frontiers in drug discovery, making her a vital figure in the quest to target the undruggable.
Research Focus
Key Achievements
Top Papers
- 1